AWS for Health: accelerating innovation through data access

Dotmatics has announced its support of the AWS for Health initiative from Amazon Web Services (AWS), which aims to improve laboratory efficiency and accelerate the pace of scientific innovation by facilitating more rapid data access, analysis and exchange between scientists worldwide.

AWS for Health is an initiative featuring services and solutions built for healthcare, biopharma, and genomics customers. The initiative enables health customers to select tools and partners for their highest-priority workloads across the health community.

Modern research projects are often carried out across collaborative networks of pharmaceutical, biotech, academic, and contract research organisations (CROs). Manual results sharing and work requests using email, file shares and reports not only delay the research cycle but also introduce potential errors in data transcription and interpretation, thus slowing innovation. Successful cross-team projects depend on real-time scientific data exchange for informed project decisions. Added to this, increased volumes and complexity of data from high throughput experimentation mean scientists must automate their workflows to ensure clean data is available to take advantage of advanced data analytics such as Artificial Intelligence (AI) and Machine Learning.

Dotmatics’ cloud-based software provides access to all research data in its own and third-party databases, coupled with informatics solutions for small molecule and biologics discovery that expedite scientific workflows and enable automation of instrument data acquisition and data processing so that in-house or multi-organisational research teams become more efficient.

Alastair Hill, Co-Founder and CIO, Dotmatics said: “Our cloud-based systems are designed to provide real-time access to all scientific project data coupled with powerful analytics and visualization, for all team members, irrespective of location. An accessible and secure data foundation is key to improving innovation through better-informed decision-making for scientists, aided by next generation AI and machine learning. We are delighted to be part of the AWS for Health initiative which brings together the best in the industry, making it easy for healthcare, biopharma, and genomics customers to find, test, buy, and deploy software that runs on AWS.”

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free